The expansion is anticipated to be fueled by the use of imaging technologies like computed tomography (CT) in the diagnosis of COPD. Market acceptance of the use of technologically sophisticated tools, including pulse oximeters, for efficient management of COPD in outpatients is growing quickly. Additionally, the switch to noninvasive mechanical ventilation for COPD is anticipated to drive market expansion.

In 2016, the market for respiratory illness diagnostics on a global scale was dominated by imaging tests. Increased use of x-ray imaging and other imaging modalities for better visualisation and a clearer picture of illness status is the main factor contributing to the segment's dominance. In addition, rising CT imaging demand is anticipated to fuel growth. Consequently, the segment is anticipated.